Hims & Hers Health, Inc. logo

Hims & Hers Health, Inc. (82W)

Market Open
3 Dec, 15:33
XDUS XDUS
30. 91
-0.99
-3.1%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-0.14 Eps
31.9
Previous Close
Day Range
30.91 31.31
Year Range
20.55 68.3
Want to track 82W and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 80 days

Summary

82W trading today lower at €30.91, a decrease of 3.1% from yesterday's close, completing a monthly decrease of -8.09% or €2.72. Over the past 12 months, 82W stock gained 28.79%.
82W is not paying dividends to its shareholders.
The last earnings report, released on Nov 03, 2025, missed the consensus estimates by -0.04%. On average, the company has fell short of earnings expectations by -0.07%, based on the last three reports. The next scheduled earnings report is due on Feb 23, 2026.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

82W Chart

A New Market, A New Catalyst: Assessing Hims & Hers' Canadian Opportunity

A New Market, A New Catalyst: Assessing Hims & Hers' Canadian Opportunity

Hims & Hers Health expands into Canada via Livewell acquisition, targeting a large, underserved weight-loss market. Canadian entry leverages local leadership and expertise, aiming to replicate successful European expansion and accelerate subscriber growth. GLP-1 weight-loss treatments drive revenue potential but introduce margin pressure and cost volatility, creating both opportunity and structural risk.

Seekingalpha | 7 hours ago
HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency

HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency

Hims & Hers is set to acquire YourBio Health, adding bladeless microneedle tech to transform the blood collection experience.

Zacks | 23 hours ago
Hims & Hers shares jump on expansion into Canada

Hims & Hers shares jump on expansion into Canada

US-based digital health company Hims & Hers Holdings Inc (NYSE:HIMS) is entering the Canadian market following its acquisition of Livewell, a Canadian telehealth platform focused on weight loss and other wellness services. The move positions Hims & Hers to launch a Canadian weight loss program in 2026, coinciding with the availability of the first generic semaglutide.

Proactiveinvestors | 1 day ago

Hims & Hers Health, Inc. (82W) FAQ

What is the stock price today?

The current price is €30.91.

On which exchange is it traded?

Hims & Hers Health, Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is 82W.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.04.

When is the next earnings date?

The next earnings report will release on Feb 23, 2026.

Has Hims & Hers Health, Inc. ever had a stock split?

No, there has never been a stock split.

Hims & Hers Health, Inc. Profile

- Industry
- Sector
Andrew Dudum CEO
XDUS Exchange
US4330001060 ISIN
US Country
1,637 Employees
- Last Dividend
- Last Split
13 Sep 2019 IPO Date

Overview

Hims & Hers Health, Inc., based in San Francisco, California, operates as a telehealth platform connecting consumers with licensed healthcare professionals across the United States, the United Kingdom, and other international locations. The company leverages its websites and mobile application to offer a variety of carefully selected health and wellness products and services, both on prescription and over-the-counter basis. Its business model focuses on providing convenient access to ongoing healthcare services, including prescription medication refills and consultations with healthcare providers, as well as a wide range of wellness products through direct sales and wholesale partnerships.

Products and Services

  • Prescription Medication: Customers can receive prescription medication on a recurring basis, ensuring continuous care and support from healthcare providers.
  • Over-The-Counter Drug and Device Products: Offers a selection of non-prescription products, including cosmetics and supplements, focused on general wellness, sexual health, skincare, and hair care.
  • Curated Non-Prescription Products: This includes:
    • Wellness Specialty: Products like melatonin for sleep and biotin for wellness.
    • Skincare Specialty: A range of skincare products including moisturizers, creams, sunscreen, serum, face oil, and face wash.
    • Sexual Health and Wellness Specialty: Items such as condoms, climax delay spray and wipes, vibrators, and lubricants.
    • Hair Care Specialty: Products like shampoos, conditioners, scalp scrubs, and topical treatments, including minoxidil.
  • Medical Consultation and Post-Consultation Support Services: Offers comprehensive consultation services and follow-up support to ensure effective healthcare management.
  • Health and Wellness Products through Wholesale Partners: Besides direct sales, the company expands its reach by distributing health and wellness products through trusted wholesale partners.

Contact Information

Address: 2269 Chestnut Street
Phone: 415 851 0195